Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy.
Goede V, Coutelle O, Neuneier J, Reinacher-Schick A, Schnell R, Koslowsky TC, Weihrauch MR, Cremer B, Kashkar H, Odenthal M, Augustin HG, Schmiegel W, Hallek M, Hacker UT. Goede V, et al. Br J Cancer. 2010 Oct 26;103(9):1407-14. doi: 10.1038/sj.bjc.6605925. Epub 2010 Oct 5. Br J Cancer. 2010. PMID: 20924372 Free PMC article.
[Chemotherapy of colorectal cancer].
Reinacher-Schick A, Pohl M, Schmiegel W. Reinacher-Schick A, et al. Internist (Berl). 2009 Nov;50(11):1239-52. doi: 10.1007/s00108-009-2508-6. Internist (Berl). 2009. PMID: 19838655 German.
[Pathogenesis of colorectal carcinoma].
Reinacher-Schick A, Schmiegel W. Reinacher-Schick A, et al. Praxis (Bern 1994). 2002 Sep 25;91(39):1589-93. doi: 10.1024/0369-8394.91.39.1589. Praxis (Bern 1994). 2002. PMID: 12391909 German.
Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group.
Müller CI, Schulmann K, Reinacher-Schick A, Andre N, Arnold D, Tannapfel A, Arkenau H, Hahn SA, Schmoll SH, Porschen R, Schmiegel W, Graeven U; AIO Colorectal Study Group. Müller CI, et al. Int J Colorectal Dis. 2008 Nov;23(11):1033-9. doi: 10.1007/s00384-008-0504-2. Epub 2008 Jul 2. Int J Colorectal Dis. 2008. PMID: 18594845 Clinical Trial.
[Colorectal carcinoma: what's new?].
Pox C, Schmiegel W, Reinacher-Schick A. Pox C, et al. Dtsch Med Wochenschr. 2012 Dec;137(49):2577-80. doi: 10.1055/s-0032-1327268. Epub 2012 Nov 27. Dtsch Med Wochenschr. 2012. PMID: 23188639 Review. German. No abstract available.
Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group.
Schmiegel W, Reinacher-Schick A, Arnold D, Kubicka S, Freier W, Dietrich G, Geißler M, Hegewisch-Becker S, Tannapfel A, Pohl M, Hinke A, Schmoll HJ, Graeven U. Schmiegel W, et al. Ann Oncol. 2013 Jun;24(6):1580-7. doi: 10.1093/annonc/mdt028. Epub 2013 Mar 4. Ann Oncol. 2013. PMID: 23463625 Free article. Clinical Trial.
174 results